BioCentury
ARTICLE | Company News

Opko acquires Cytochroma

January 10, 2013 1:01 AM UTC

Opko Health Inc. (NYSE:OPK) will acquire Cytochroma Inc. (Markham, Ontario) for $100 million in stock, plus up to $190 million in milestones. Opko will gain Cytochroma's two lead programs: Replidea ( ...